SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 63 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $76,150,000 | -30.7% | 41,769,000 | -8.1% | 0.03% | -34.1% |
Q3 2014 | $109,884,000 | +20.1% | 45,430,000 | -2.6% | 0.04% | +22.2% |
Q2 2014 | $91,527,000 | +16.4% | 46,623,000 | +0.2% | 0.04% | +12.5% |
Q1 2014 | $78,660,000 | +15.6% | 46,527,000 | +1.9% | 0.03% | +18.5% |
Q4 2013 | $68,041,000 | +22.1% | 45,646,000 | +0.5% | 0.03% | +12.5% |
Q3 2013 | $55,705,000 | +2.9% | 45,404,000 | +0.1% | 0.02% | -4.0% |
Q2 2013 | $54,115,000 | – | 45,356,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $4,916,000 | 4.33% |
SYMPHONY ASSET MANAGEMENT LLC | 19,840,000 | $38,948,000 | 4.05% |
SILVERBACK ASSET MANAGEMENT LLC | 19,709,000 | $38,695,000 | 4.00% |
MACKAY SHIELDS LLC | 31,471,000 | $61,916,000 | 3.41% |
Sage Capital Management, LLC | 1,500,000 | $2,942,000 | 2.98% |
ALTEGRIS ADVISORS, L.L.C. | 250,000 | $491,000 | 2.56% |
Wellesley Asset Management | 16,220 | $31,923,000 | 2.01% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $16,883,000 | 1.62% |
CAMDEN ASSET MANAGEMENT L P /CA | 13,862,000 | $27,213,000 | 1.58% |
Calamos Wealth Management LLC | 2,061,000 | $4,045,000 | 1.15% |